BANK OF AMERICA CORP /DE/
BankPosition in KALV — KalVista Pharmaceuticals, Inc.
CIK 70858
CHARLOTTE, NC
Position in KALV
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$11,184,790
+$4,889,312 QoQ
Shares Held
555,628
+42.5% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88.46188457025204.ToString("F0")%
Shared 0.ToString("F0")%
None 11.538115429747961.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,548,750,242 across 347 Biotechnology names. KALV ranks #98 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,184,790 | 555,628 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $6,295,478 | 389,813 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,438,500 | 364,409 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $4,148,549 | 366,966 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,557,169 | 308,247 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $932,122 | 110,050 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $610,195 | 52,694 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $736,331 | 62,507 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $284,105 | 23,955 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $399,239 | 32,591 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $216,298 | 22,461 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $189,423 | 21,047 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $179,475 | 22,834 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $120,652 | 17,848 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $83,664 | 5,766 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $77,116 | 7,837 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,032,801 | 70,068 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $891,053 | 67,351 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $231,175 | 13,248 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $280,020 | 11,687 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $493,143 | 19,196 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $250,420 | 13,187 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $188,409 | 14,965 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $230,346 | 19,037 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $153,175 | 20,023 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||